These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 22283464

  • 1. Cochlear function in Ménière's disease.
    Büki B, Jünger H, Avan P.
    Int J Audiol; 2012 May; 51(5):373-8. PubMed ID: 22283464
    [Abstract] [Full Text] [Related]

  • 2. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B, Platz M, Haslwanter T, Jünger H, Avan P.
    Audiol Neurootol; 2011 May; 16(1):49-54. PubMed ID: 20523039
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin injections for the treatment of Ménière's disease.
    Katzenell U, Gordon M, Page M.
    Otolaryngol Head Neck Surg; 2010 Nov; 143(5 Suppl 3):S24-9. PubMed ID: 20970688
    [Abstract] [Full Text] [Related]

  • 4. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 6. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 May; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 7. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 8. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 9. [Intratympanic gentamicin in Menière's disease].
    Huang W, Xu H, Gao B.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [Abstract] [Full Text] [Related]

  • 10. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 11. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 12. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 14. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN, Akkuzu G, Ozgirgin N, Tarhan E.
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [Abstract] [Full Text] [Related]

  • 15. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 16. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W, Szyfter W, Lączkowska-Przybylska J, Szyfter-Harris J.
    Otolaryngol Pol; 2012 Feb; 66(1):20-6. PubMed ID: 22381010
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 18. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T, Halmagyi GM, Yavor RA.
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [Abstract] [Full Text] [Related]

  • 19. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.
    Scarpa A, Ralli M, Cassandro C, Gioacchini FM, Alicandri-Ciufelli M, Viola P, Chiarella G, de Vincentiis M, Cassandro E.
    Am J Otolaryngol; 2019 Jan; 40(6):102289. PubMed ID: 31537428
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.